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ABSTRACT 
The control of phosphorus and calcium metabolism is one of the objectives in treatment protocol for CKD patients. The levels of 
these minerals in serum are affected by dietary patterns and nutritional status of the patients. India being a large country, diet 
patterns vary from one state to another. Thus, we suspect a close association between dietary intake and alterations in homeostasis 
of calcium and phosphorus in CKD patients. Therefore, we conduct this study to describe the effect of dietary factors and 
nutritional status on serum calcium and phosphorus levels in CKD patients on treatment in a tertiary care setting in North India. In 
the present study 330 CKD patients coming to dialysis unit, were recorded with detailed Medical history as well as baseline 
demographic data. Also, biochemical analysis of serum albumin corrected, calcium, phosphorus, and serum albumin of all cases 
were done using fully automated equipment. All statistical analyses were performed using SPSS statistical software, version 17.  
Majority (58.2 %) of the study patients were vegetarians with a mean value of BMI (Mean±SD=23.75±4.70 kg/m2). A negative but 
significant correlation was found between corrected calcium and phosphorus with 0.05 level of confidence interval (r=-0.149, p= 
0.007). It was found that the well-nourished patients were more likely to be hyperphosphatemic as compared to poorly nourished 
patients, but statistically the values were found to be non significant (Statistically p-value was not less than 0.05).   
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INTRODUCTION 
Chronic kidney disease (CKD) is a global health 
problem that affects 5% to 10% of the World 
population
1
, with increasing prevalence and poor 
outcomes, with progressive loss of renal functions, 
cardiovascular disease, and early death
2-4
. 
Chronic kidney disorders have a progressive pattern in 
most cases taking months to years, and finally result in 
end-stage renal disease (ESRD)
3,5
. When renal function 
drops below 10 to 15 percent of the normal function 
ESRD is reached
6
. For the composition of bones and 
the regulation of several processes in the body, calcium 
and phosphorus have great importance
7
. The kidney 
plays important role in achieving calcium and 
phosphorus homeostasis in collaboration with other 
organs i.e. the parathyroid gland, intestines, and bones. 
Thus, along with the progression of chronic kidney 
disease (CKD), numerous abnormalities (like hypocal-
cemia, hyperphosphatemia and hyperparathyroidism) 
develop, which can result in noteworthy 
consequences
8
. Instabilities in mineral metabolism in 
CKD which result in multisystem disorder have now 
been given a distinct identity as CKD-MBD (Chronic 
Kidney Disease-Mineral and Bone disorder) by 
KDIGO
9,10
. KDIGO (Kidney Disease: Improving 
Global Outcomes) is an international initiative with a 
key mission of developing evidence-based clinical 
practice guidelines for the prevention, diagnosis, 
evaluation, and treatment of chronic kidney disease and 
has added “Mineral and Bone Disorder to CKD to be 
now called as CKD–MBD”10,11. These Guidelines for 
bone metabolism and disease in CKD (USA) 
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recommend that, the target levels for calcium (Ca) 
(corrected for serum albumin), phosphorus (P) and 
calcium×phosphorus (Ca×P) product levels should be 
maintained at 8.5-10.5 mg/dl, 2.5-4.5 mg/dl and <55 
mg
2
/dl
2
, respectively. 
The control of calcium and phosphorus metabolism is 
one of the objectives in an acceptable treatment 
protocol for CKD patients. The levels of these minerals 
in serum are also affected by dietary patterns and 
nutritional status of the patients. India being a large 
country, diet patterns vary from one state to another. 
Thus, we suspect a close association between dietary 
intake and alterations in calcium and phosphorus 
homeostasis in CKD patients and hence we conducted 
the present study.  
  
MATERIALS AND METHODS 
Study Design:  
This study was a cross-sectional observational study.  
Research Setting:  
The study was conducted at the Gian Sagar Medical 
Hospital, Ramnagar, Patiala, under the Department of 
Physiology and dialysis unit, department of Medicine. 
Study Population and Study Period: 330 Chronic 
Kidney Disease Patients>18 years of age and belonging 
to both sexes were on maintenance hemodialysis in 
dialysis unit of Gian Sagar Medical College and 
Hospital, Ramnagar (Patiala) over a period from 
December, 2012 to December, 2016. Each patient was 
considered only once for the study.  
Ethical approval and informed consent:  
After approval by ethical committee of Gian Sagar 
medical College and Hospital, this study was initiated. 
An informed consent was taken from all the subjects 
before inclusion in the study.  
Data Collection and statistical analysis:  
The study was started after proper approval from 
Institutional Research Ethics Committee. Patients were 
selected based upon the inclusion and exclusion 
criteria.  
 
Figure 1: Distribution according to Dietary History 
in CKD patients. 
Approach to a Patient began by taking informed 
consent. The baseline demographic data like age (yrs.), 
gender (M/F), weight (Kg), height (cm), BMI (Body 
Mass Index), religion, educational status 
(literate/illiterate), environmental status (urban/rural), 
were recorded. Blood sample was collected for 
laboratory investigations (like Serum calcium, Serum 
phosphorous, Serum albumin, and Hemoglobin).  
Five milliliters of blood were taken from the 
antecubital vein of the patients under full aseptic 
conditions. Serum was separated out for the estimation 
of biochemical parameters upon clotting. Fully 
automated equipments standardized in Gian Sagar 
Hospital were used to perform these tests. Dietary 
history of the patients was taken in detail.  
 
Figure 2: Distribution according to nutritional 
Status in CKD patients. 
Nutritional status of the patients was assessed by 
measuring BMI (Body Mass Index)
12
. Detailed history 
regarding the intake of both calcium-based and Non-
calcium-based phosphate binders and Vitamin D 
analogues was taken.  
 
Figure 3: Alterations of Calcium level in CKD 
patients 
Normal values of serum calcium (corrected for 
albumin) and phosphate were defined as 8.5-10.5 mg/dl 
and 2.5-4.5 mg/dl respectively. The detailed data 
related to CKD-MBD was recorded. Observations and 
results were compiled at the end of the study. The 
control of CKD-MBD was assessed as recommended 
by KDIGO guidelines. Appropriate statistical methods 
were employed to compare all the Demographic and 
laboratory parameters using statistical package for 
social sciences SPSS (Statistical Package for Social 
Science) package version 17.0.  
 
Table 1. Distribution of cases by levels of 
Laboratory Parameters in CKD patients 
Laboratory 
characteristics 
of Patients 
Groups Number of 
CKD patients 
(n = 330) 
% 
Albumin-
corrected 
serum 
Ca(mg%) 
Less than 8.5 167 50.6 
8.5-10.5 146 44.2 
More than 
10.5 
17 5.2 
Serum 
phosphorus 
level (mg%) 
Less than 2.5 3 .9 
2.5-4.5 122 37.0 
More than 
4.5 
205 62.1 
Descriptive statistics such as range, mean and standard 
deviation were used to describe continuous variables 
while numbers and percentages were used to present 
discreet variables.  
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Figure 4: Alterations of Phosphorus level in CKD 
patients 
Chi square test was used to test association between 
Demographical and laboratory parameters and 
Pearson’s coefficient of correlation were used to assess 
the inter-relationship between various examined 
laboratory markers. The result was statistically 
significant when the P-value was less than 0.05.   
Observations:  
In present study 66.4 % patients predominantly 
belonged to the rural area as compared to 33.6% urban 
area. Majority (58.2%) of the study patients were 
taking vegetarian diet in the present study (Figure 1 
and Figure 2). Majority (62%) of patients had 
hyperphosphatemia as compared to hypophosphatemia 
(1%, only) (Figure 4).  
Statistical analysis:  
Chi-square tests were used to see association between 
Phosphorus levels (hypo, normal and hyperphospha-
temia) and other demographic variables like Dietary 
Factors and Nutritional status of the study patients. 
Pearson’s Chi square test (Yates’s correction for 
continuity) was used to examine the significance of 
association (contingency). 
Table 2: Association of phosphorus levels with demographic history of the study patients 
Patient 
characteristics 
(Demographic 
history) 
 Phosphorus level χ2 
value 
P-value 
 Low 
(<2.5mg%) 
Normal  
(2.5 – 4.5mg %) 
High  
(>4.5mg%) 
 
Age 
 
20 – 40 1 (1.4%) 28 (38.4%) 44 (60.3%) 2.752 0.839NS 
41 – 60 2 (1.3%) 62(39.0%) 95 (59.7%) 
61 – 80 0 (0.0%) 29 (33.3%) 58 (66.7%) 
>80  0 (0.0%) 3  (27.3%) 8  (72.7%) 
Sex Female 2(1.7%) 46 (40.0%) 67 (58.3%) 2.200 0.333NS 
Male 1 (0.5%) 76 (35.3%) 138 (64.2%) 
Religion Hindu 0 (0.0%) 49 (40.2%) 73 (59.8%) 4.276 0.370NS 
Muslim 0 (0.0%) 1(100.0%) 0 (.0%) 
Sikh 3 (1.4%) 72 (34.8%) 132 (63.8%) 
Environmental 
status 
Rural 2 (0.9%) 81 (37.0%) 136 (62.1%) .000 1.000NS 
Urban 1 (0.9%) 41 (36.9%) 69 (62.2%) 
Educational 
status 
Illiterate 2 (1.1%) 68 (37.8%) 110 (61.1%) .313 0.855NS 
Literate 1 (0.7%) 54 (36.0%) 95 (63.3%) 
Nutritional Status Poor 0(.0%) 3(42.9%) 4(57.1%) .161 0.923NS 
Well 3(0.9%) 119(36.8%) 201(62.2%) 
Dietary History Non-
vegetarian 
2 (1.4%) 55 (39.9%) 81 (58.7%) 1.743 0.418NS 
Vegetarian 1 (.5%) 67 (34.9%) 124 (64.6%) 
 
 
Figure 5: Association of Phosphorous level with other variables 
RESULTS 
It was observed that the percentage of vegetarians who 
were hyperphosphatemic was more than non 
vegetarians and also found that the well nourished 
patients were more likely to be hyperphosphatemic as 
compared to poorly nourished patients, but statistically 
the values were found to be non significant (Table 2) 
The Figure 5 clearly shows hyperphosphatemia as a 
constant finding in all baseline demographic 
parameters of the CKD patients. In addition to this both 
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poorly nourished patients and well nourished patients 
showed hyperphosphatemia. Similar findings were 
reported in both vegetarian and non vegetarian patients. 
A negative but significant correlation was found 
between corrected Ca and phosphorus with 0.05 level 
of confidence interval (r=-0.149, p= 0.007).  
 
DISCUSSION  
The minerals like calcium and phosphorus disrupted in 
CKD are critically important in the regulation of both 
initial bone formation during growth (bone modelling) 
and bone structure and function during adulthood (bone 
remodelling)
9
. As a result, bone abnormalities are 
found almost universally in patients with progressive 
loss of renal function in CKD
9
. Calcium and 
Phosphorus alterations in CKD patients can be 
attributed to many causes. 
 
Figure 6: Relationship between corrected Calcium 
with Phosphorus among cases 
Present study population of 330 patients comprised 
adults, mainly illiterate (54.5%), and coming from 
rural-strata (66.4%) with a mean age of 52.67±15.05 
(range 25 to 98 years), of whom mostly patients were 
taking vegetarian diet (58.2%).The mean age of our 
study population was similar to other studies like a 
mean age of 49.3 years with range 17-80
13
 and a mean 
age of 46.6±13.4 years
14
. However, higher mean age 
was reported in other Western and Indian studies
15-17
. 
In the present study it was observed that alterations in 
biochemical profile were common in CKD patients. 
55.8% of patients for corrected serum calcium and 
63.0% of patients for phosphorus were out of the target 
range. 
The percentage of patients, who were in the 
recommended range, was less than that obtained in 
other studies
18,19
. The inability of the CKD Patients to 
achieve the above said target range may be on account 
of implementing different modalities for regulation of 
calcium and phosphorus levels in Indian dialysis 
population as given below: - 
1. Patients were using calcium based phosphate 
binders only (like calcium acetate or calcium 
carbonate) in our centre as compared to non-
calcium based phosphate binders (like sevelamer 
hydrochloride, or lanthanum carbonate, which is 
widely used in USA and Europe for the treatment 
of hyperphosphatemia in patients with CKD
20-21
. 
2. In our centre (Punjab region) we found patients 
were taking diet mostly of milk, cheese, and butter 
with high content of phosphorous due to easily 
availability because most of the rural households 
have cattle of their own and believed that milk and 
milk products are of high nutritional value in all 
aspects. They would also sometimes replace meals 
with milk so balanced nutrition is not achieved in 
such cases.  
3. In addition to this, the consumption of alcoholic 
beverages also high in Punjab and these factors also 
contributes to hyperphosphatemia seen in patients 
from this region. 
4. Moreover, phosphate binders as prescribed by 
nephrologist to cure this problem were not properly 
adhered to by dialysis patients. Evidence of present 
study showed that 75.8 % CKD patients were not 
using the phosphate binders. Only 24.2% CKD 
Patients were using these binders (calcium-based 
phosphate binders). 
Serum calcium, phosphorus concentrations should 
therefore be measured in all CKD patients on a regular 
basis. Measurements should be made more frequently 
when a patient receives concomitant therapy for 
anomalies in plasma calcium and phosphorus
22
. To 
obtain low phosphorus levels an adequate management 
program is necessary, which can only be accomplished 
by thorough dietary counselling and administration of a 
balanced mix of medications. The diets rich in 
phosphorus such as milk, cheese, dried beans, peas, 
nuts, and peanut butter and Drinks like cocoa, dark 
sodas, and beer should be consumed in quantities 
which are strictly recommended by an expert renal 
dietician. Its required medications called phosphate 
binders (such as calcium carbonate (Tums), calcium 
acetate (PhosLo), sevelamer hydrochloride (Renagel), 
or lanthanum carbonate (Fosrenol) may also be added 
with meals and snacks to bind phosphorus in the 
bowel. These medications decrease the absorption of 
phosphorus into the blood.  
Overall, reducing dietary intake of phosphorus in 
dialysis patients is one of the most important steps in 
controlling PTH levels. Overactive parathyroid glands 
are controllable with a change in diet, dialysis 
treatment, or medication in most of the cases. A dietary 
plan to control phosphorus levels in the blood should 
be developed by a qualified renal dietician. Strict 
compliance to the diet must be done by the patients and 
physicians should motivate the patients to do the same. 
 
CONCLUSION 
Our findings support a strict control of mineral 
metabolism in CKD patients. The importance of 
educating and stimulating dialysis patients in order to 
achieve optimal observance to the treatment program 
and dietary suggestions should be highlighted to both 
patients and doctors. A strict dietary plan along with 
inclusion of phosphate binders in diet to control 
phosphorus levels in the blood should be provided by 
the renal dietician. Regular dietary follow-ups and 
counselling is necessary to ensure the success of diet 
and treatment programmes. The aim of the treatment 
must be control of phosphate retention, maintaining 
serum calcium concentration within the normal range 
(standard), with prevention of hypercalcaemic 
incidents.  
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